[Present and future of trial design].

Area of Science:

• Clinical research methodology
• Evidence-based medicine
• Study design

Background:

• A wide array of clinical study designs are available, categorized by various parameters like observational vs. experimental and prospective vs. retrospective.
• Randomized double-blind trials offer the highest level of control and minimal bias but face limitations due to ethical, economic, and generalizability concerns.

Purpose of the Study:

• To address the limitations of current clinical trial designs.
• To identify research methodologies that provide high-quality evidence.
• To explore designs that can substitute for experiments when necessary and overcome randomized clinical trial constraints.

Main Methods:

• Review and classification of existing clinical study designs.
• Analysis of the strengths and weaknesses of different research methodologies.
• Discussion of the impact of study design on evidence quality and clinical decision-making.

Main Results:

• The randomized double-blind trial is the gold standard for control but is not always feasible.
• A trend towards poorly controlled studies may yield weak evidence, potentially harming patients and the economy.
• There is a critical need for alternative study designs.

Conclusions:

• The development of innovative clinical study designs is crucial.
• New methodologies must balance rigor with practicality, ethical considerations, and generalizability.
• Future research designs should aim to provide robust evidence while overcoming the inherent limitations of traditional randomized trials.